Severe Pulmonary Cryptococcosis in an Immunocompetent Patient Presenting With Acute Respiratory Failure
Abstract
Pulmonary cryptococcosis may present with nonspecific respiratory symptoms and, in patients with underlying reactive airway disease, can act as a trigger for refractory asthma exacerbation leading to acute respiratory failure, even in immunocompetent individuals. A 60-year-old immunocompetent male, with a negative HIV test, no chronic immunosuppressive therapy, and a remote brief corticosteroid course well below the threshold for clinically significant immunosuppression, presented with approximately two months of progressive dyspnea and cough after multiple treatment courses for presumed asthma exacerbations and bronchitis without improvement. His condition deteriorated during hospitalization, requiring noninvasive ventilation followed by endotracheal intubation for acute hypoxic respiratory failure driven by a refractory asthma exacerbation. The clinical presentation closely mimicked bacterial pneumonia superimposed on asthma exacerbation, with CT imaging demonstrating bronchial wall thickening and mucous plugging, which initially precluded suspicion of a fungal etiology. Serum cryptococcal antigen was negative. An extensive noninvasive infectious workup remained unrevealing, and broad-spectrum antibiotics and bronchodilator therapy failed to produce improvement. On hospital day five, bronchoscopy with bronchoalveolar lavage (BAL) was performed, given persistent hypoxemia and diagnostic uncertainty, with BAL fungal culture growing Cryptococcus neoformans and establishing…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Impact of antibiotics on the human microbiome and consequences for host health
- Antibiotics in the clinical pipeline in October 2019
- The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan
- Research Communications of the 32nd ECVIM-CA Online Congress
- Singlet-Oxygen Therapy. Scientific And Methodological Materials
- Artificial Intelligence in Pharmacovigilance
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.